# AZEVAN PHARMACEUTICALS INC: Form D filing

AZEVAN PHARMACEUTICALS INC, a pharmaceuticals company in Bethlehem, PA, filed a Form D with the SEC in 2013. The latest, on October 18, 2013, reports $2.2 million sold of a $6.5 million offering to 4 investors.

Find out what AZEVAN PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AZEVAN%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AZEVAN%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fazevan-pharmaceuticals-inc-1334514)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AZEVAN%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AZEVAN%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fazevan-pharmaceuticals-inc-1334514)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 116 RESEARCH DRIVE, Bethlehem, PA, 18015
- Phone: (610) 419-1057
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1334514

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 18, 2013 | New notice | $6,500,000 | $2,205,000 | $4,295,000 | 4 | Oct 4, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1334514/000133451413000003/0001334514-13-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Geoffrey G. Smith | Director |  |
| Morton G. Hyman | Director |  |
| Neal G. Simon | Executive Officer, Director |  |
| Mike G. Pavia | Director |  |
| Paul J. Maddon | Director |  |
| Carter G. Meyer | Director |  |

## Other pharmaceuticals companies in Pennsylvania that filed recently

- [Telemachus Therapeutics, Inc.](https://specstream.ai/data/form-d/company/telemachus-therapeutics-inc-2152986) $375,000 · Oct 28, 2026
- [EpiVario Inc.](https://specstream.ai/data/form-d/company/epivario-inc-1753351) $185,000 · Oct 13, 2026
- [Maxona Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/maxona-pharmaceuticals-inc-1857448) $5.8 million · Aug 14, 2026

[Every Form D from the week of Oct 14, 2013](https://specstream.ai/data/form-d/week/2013-10-14) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what AZEVAN PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).